These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306 [TBL] [Abstract][Full Text] [Related]
3. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630 [TBL] [Abstract][Full Text] [Related]
4. A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Piraino B; Bernardini J; Sorkin M Am J Kidney Dis; 1987 Oct; 10(4):281-6. PubMed ID: 3661549 [TBL] [Abstract][Full Text] [Related]
5. Prevention of catheter related infections in patients on CAPD. Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317 [TBL] [Abstract][Full Text] [Related]
6. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience. Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797 [TBL] [Abstract][Full Text] [Related]
7. Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis. Bayston R; Andrews M; Rigg K; Shelton A Perit Dial Int; 1999; 19(6):550-5. PubMed ID: 10641776 [TBL] [Abstract][Full Text] [Related]
8. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis. Ludlam HA; Young AE; Berry AJ; Phillips I J Hosp Infect; 1989 Nov; 14(4):293-301. PubMed ID: 2575628 [TBL] [Abstract][Full Text] [Related]
9. Peritonitis associated with exit site and tunnel infections. Gupta B; Bernardini J; Piraino B Am J Kidney Dis; 1996 Sep; 28(3):415-9. PubMed ID: 8804241 [TBL] [Abstract][Full Text] [Related]
11. Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis. Ndlovu KCZ; Swe Swe-Han K; Assounga A Ren Fail; 2019 Nov; 41(1):303-313. PubMed ID: 30991864 [TBL] [Abstract][Full Text] [Related]
13. Adherence of Staphylococcus aureus isolated in peritoneal dialysis-related exit-site infections to HEp-2 cells and silicone peritoneal catheter materials. Kreft B; Ilic S; Ziebuhr W; Kahl A; Frei U; Sack K; Trautmann M Nephrol Dial Transplant; 1998 Dec; 13(12):3160-4. PubMed ID: 9870482 [TBL] [Abstract][Full Text] [Related]
14. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience. Cho KH; DO JY; Park JW; Yoon KW Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821 [TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus infections in dialysis patients: focus on prevention. Piraino B ASAIO J; 2000; 46(6):S13-7. PubMed ID: 11110288 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122 [TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections. Herwaldt LA Perit Dial Int; 1993; 13 Suppl 2():S301-5. PubMed ID: 8399593 [No Abstract] [Full Text] [Related]